The Record: Monday, July 11th, Full Show
Coming out of last week's killings by police and of police we give you some ideas of things you can do about violence and injustice.
Also, a Seattle biotech company suffered a major blow when three people died in a clinical trial and the FDA stopped the trial. How big a setback is this for Juno Therapeutics and the treatment of cancer?
And finally, comedian Jessi Klein will tell you why we love tomboys but not tommen.
Listen to the full show above or check out an individual story:
- After clinical trial hold and plunging stock, what's next for Juno Therapeutics?
- Local tech zooms forward with Pokemon Go and Amazon Dash
- Are we seeing the end of green space in the Emerald City?